Genetic diversity at the p53 locus between primary human colorectal adenocarcinomas and their lymph-node metastases

International Journal of Cancer

Volumn 70, Issue 6, 1997, Pages 674-678

  Zhang, Jin Sheng ^a,b   Caplin, Scott ^b   Bosman, Fred T ^b   Benhattar, Jean ^b,c  

^a FUDAN UNIVERSITY   (China)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; FEMALE; GENES, P53; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 0030993948     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970317)70:6<674::AID-IJC8>3.0.CO;2-S     Document Type: Article

References (27)

1. ARENDS, J.W., SCHUTTE, B., WIGGERS, T., VERSTUNEN, C.P., BLIJHAM, G.H. and BOSMAN, F.T., Comparison of phenotypic and genotypic features in human primary large-bowel carcinomas and lymph-node metastases. Cancer Res., 47, 4342-4344 (1987).
2. BAKER, S.J., PRESINGER, A.C., JESSUP, J.M., PARASKEVA, C., MARKOVITZ, S., WILSON, J.K.V., HAMILTON, S. and VOGELSTEIN, B., p53-gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50, 7717-7722 (1990).
3. BAUTISTA, D., CHAUBERT, P., BERTONCINI, J. and BENHATTAR, J., Detection of p53-gene mutation in cancer tissues by non-radioactive direct sequencing. PCR Methods Applications, 4, 76-79 (1994).
4. CALVERT, R.J., WEGHORST, C.M. and BUZARD, G.S., PCR amplification of silver-stained SSCP bands from cold SSCP gels. BioTechniques, 18, 782-786 (1995).
5. CARSON, D.A. and Lois, A., Cancer progression and p53. Lancet, 346, 1009-1011 (1995).
6. CHAUBERT, P., BAUTISTA, D. and BENHATTAR, J., An improved method for rapid screening of DNA mutations by non-radioactive singie-strand conformation polymorphism procedure. BioTechniques, 15, 586 (1993).
7. CORDON-CARDO, C., Mutation of cell-cycle regulators, biological and clinical implications for human neoplasis. Amer. J. Pathol., 147, 545-560 (1995).
8. Dix, B.R., ROBBINS, P.D., SPAGNOLO, D.V., PADOVAN, G.L., HOUSE, A.K. and IACOPETTA, B.J., Clonal analysis of colorectal tumors using K-ras and p53 gene mutations as markers. Diagn. mol. Pathol., 4, 261-265 (1995).
9. FROGGATT, N.J., LEVESON, S.H. and GARNER, R.C., Low frequency and late occurrence of p53 and dcc aberrations in colorectal tumours. J. Cancer Res. clin. Oncol., 121, 7-15 (1995).
10. GOH, H.S., CHAN, C.S., KHINE, K. and SMITH, D.R., p53 and behaviour of colorectal cancer. Lancet, 344, 233-234 (1994).
11. GRAHAM, R.A., TEAGUE, K., MCLEMORE, D., CLEARY, K. and EL-NAGGAR, A., Regional DNA content heterogeneity in colonic adenocarcinoma: prognostic significance in patients with liver metastasis. J. surg. Oncol., 50, 228-232 (1992).
12. HAMELIN, R., LAURENT-PUIG, P., OLSCHWANG, S., JEGO, N., ASSELAIN, B., REMVIKOS, Y. GIRODET, J. and SALMON, R.J., Association of p53 mutations with short survival in colorectal cancer. Gastroenterology, 106, 42-48 (1994).
13. ISAACS, W.B., CARTER, B.S. and EWING, C.M., Wild-type p53-suppressor growth of human prostate-cancer cells containing mutant p53 alleles. Cancer Res., 51, 4716-4720 (1991).
14. KANJILAL, S., PIERCEALL, W.E., CUMMINGS, K.K., KRIPKE, M.L. and ANANTHASWAMY, H.N., High frequency of p53 mutations in ultraviolet-radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity. Cancer Res., 53, 2961-2964 (1993).
15. KASTRINAKIS, W.V., RAMCHURREN, N., RIEGER, K.M., HESS, D.T., LODA, M., STEELE, G. and SUMMERHAYES, I.C., Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogene, 11, 647-652 (1995).
16. KONISHI, N., HIASA, Y., MATSUDA, H., TAO, M., TSUZUKI, T., HAYASHI, I., KITAHORI, Y., SHIRAISHI, T., YATANI, R., SHIMASAKI, J. and LIN, J.C., Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor-suppressor gene in human prostate carcinoma. Amer. J. Pathol., 147, 1112-1122 (1995).
17. LEVINE, A.J., Tumor-suppressor genes. In: J. Mendelsohn, P.M. Howley, M.A. Israel and L.A. Liotta (eds.). The molecular basis of cancer, pp. 94-98, WB Saunders, Philadelphia (1995).
18. MURAKAMI, Y., HAYASHI, K., HIROHASHI, S. and SEKIYA, T., Aberrations of the tumor-suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res., 51, 5520-5525 (1991).
19. NAGEL, S., BORISCH, B., THEIN, S.L., OBSTREICHER, M., NOTHIGER, F., BIRRER, S., TOBLER, A. and FEY, M.F., Somatic mutations detected by mini-and microsatellite DNA markers reveal clonal intratumor heterogeneity in gastrointestinal cancers. Cancer Res., 55, 2866-2870 (1995).
20. REICHEL, M.B., OHGAKI, H., PETERSEN, I. and KLEIHUES, P., p53 mutations in primary human lung tumors and their metastases. Mol. Carcinogenesis, 9, 105-109 (1994).
21. RICEVUTO, E., FICORELLA, C., FUSCO, C., CANNITA, K., TESSITORE, A., TONIATO, E., GABRIELE, A., FRATI, L., MARCHETTI, P., GULINO, A. and MARTINOTTI, S., Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation. Amer. J. Pathol, 148, 405-413 (1996).
22. RUNNENBAUM, LB., NAGARAJAN, M., BOWMAN, M., SOTO, D. and SUKUMAR, S., Mutations in p53 as potential molecular markers for human breast cancer Proc. nat. Acad. Sci. (Wash.), 88, 10657-10661 (1991).
23. SHEKHAR, P.V., WERDELL, J., CHRISTMAN, J.K. and MILLER, F.R., Heterogeneity in p53 mutations in mouse mammary-tumor sub-populations with different metastatic potential from the orthotopic site. Anticancer Res., 15, 815-820 (1995).
24. SHIBATA, D., SCHAEFFER, J., Li, Z.H., CAPELLA, G. and PERUCHO, M., Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas. J. nat. Cancer Inst., 85, 1058-1063 (1993).
25. SIDRANSKY, D., MIKKELSEN, T., SCHWECHHEIMER, K., ROSENBLUM, M.L., CAVENEE, W. and VOGELSTEIN, B., Clonal expansion of p53 mutant cells is associated with brain-tumor progression. Nature (Lond.), 355, 846-847 (1992).
26. STRICKLER, J.G., ZHENG, J., SHU, Q., BURGART, L.J., ALBERTS, S.R. and SHIBATA, D., p53 mutations and microsatellite instability in sporadic gastric cancer: when guardians fail. Cancer Res., 54, 4750-4755 (1994).
27. VAN DEN BROEK, M.H., RENAULT, B., FODDE, R., VERSPAGET, H., GRIFFIGEN, G. and MEERA KHAN, P., Sites and types of p53 mutations in an unselected series of colorectal cancers in The Netherlands. Anticancer Res., 13, 587-5921, 1993).